首页 > 最新文献

Techniques and Innovations in Gastrointestinal Endoscopy最新文献

英文 中文
Endoscopic Ultrasound-Guided Pancreatic Fluid Collection Drainage and Pancreatic Ductal Drainage 超声内镜引导下胰液收集引流及胰管引流
IF 1.2 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 DOI: 10.1016/j.tige.2025.250921
Sridhar Sundaram , Surinder Singh Rana
Peripancreatic fluid collections (PFCs) are common complications associated with acute and chronic pancreatitis. Symptomatic PFCs need drainage, and endoscopic ultrasound (EUS) is the current standard of care. Various factors like the size, location, presence of debris in the collection, and general condition of the patient drive the choice of technique for EUS-guided transmural PFC drainage. While plastic stents were initially used, specially designed lumen-apposing and biflanged metal stents have revolutionized therapy for pancreatic necrotic collections. Minimally invasive approach in the form of endoscopic necrosectomy is now established as part of the step-up approach for performing debridement. PFCs are also often associated with disconnected pancreatic duct, which is a difficult situation to manage with evolving evidence. Pancreatic ductal obstruction due to strictures and stones represent indications for endoscopic intervention with stent placement to reduce ductal hypertension. EUS-guided pancreatic duct drainage represents an alternative in patients where endoscopic retrograde cholangiopancreatography fails or is not feasible. Either transmural or transpapillary approaches have been described. In this review, we discuss the role of EUS in drainage of PFCs along with technical tips for the same. We also discuss in detail technical steps and accessories and provide a critical appraisal on evidence for EUS-guided pancreatic duct drainage.
胰周积液(pfc)是急性和慢性胰腺炎的常见并发症。有症状的PFCs需要引流,内镜超声(EUS)是目前的标准治疗方法。各种因素,如大小、位置、收集物中碎片的存在以及患者的一般情况,决定了eus引导下经壁PFC引流技术的选择。虽然最初使用的是塑料支架,但专门设计的腔旁置和双法兰金属支架已经彻底改变了胰腺坏死集合的治疗方法。以内窥镜坏死切除术形式的微创入路现已被确立为进行清创的升级入路的一部分。pfc也经常与胰管断开有关,随着证据的不断发展,这是一个难以处理的情况。胰腺导管狭窄和结石引起的梗阻是内镜下支架置入术降低导管高血压的指征。eus引导胰管引流是内镜逆行胰胆管造影失败或不可行的患者的一种选择。经壁入路或经乳头入路均有报道。在这篇综述中,我们讨论了EUS在pfc引流中的作用以及技术提示。我们还详细讨论了技术步骤和附件,并对eus引导胰管引流的证据进行了批判性评估。
{"title":"Endoscopic Ultrasound-Guided Pancreatic Fluid Collection Drainage and Pancreatic Ductal Drainage","authors":"Sridhar Sundaram ,&nbsp;Surinder Singh Rana","doi":"10.1016/j.tige.2025.250921","DOIUrl":"10.1016/j.tige.2025.250921","url":null,"abstract":"<div><div>Peripancreatic fluid collections (PFCs) are common complications associated with acute and chronic pancreatitis. Symptomatic PFCs need drainage, and endoscopic ultrasound (EUS) is the current standard of care. Various factors like the size, location, presence of debris in the collection, and general condition of the patient drive the choice of technique for EUS-guided transmural PFC drainage. While plastic stents were initially used, specially designed lumen-apposing and biflanged metal stents have revolutionized therapy for pancreatic necrotic collections. Minimally invasive approach in the form of endoscopic necrosectomy is now established as part of the step-up approach for performing debridement. PFCs are also often associated with disconnected pancreatic duct, which is a difficult situation to manage with evolving evidence. Pancreatic ductal obstruction due to strictures and stones represent indications for endoscopic intervention with stent placement to reduce ductal hypertension. EUS-guided pancreatic duct drainage represents an alternative in patients where endoscopic retrograde cholangiopancreatography fails or is not feasible. Either transmural or transpapillary approaches have been described. In this review, we discuss the role of EUS in drainage of PFCs along with technical tips for the same. We also discuss in detail technical steps and accessories and provide a critical appraisal on evidence for EUS-guided pancreatic duct drainage.</div></div>","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 3","pages":"Article 250921"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144107474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic Sleeve Gastroplasty Reduces Atherosclerotic Cardiovascular Disease Risk: A Cohort Study Using Pooled Cohort Equations and Predicting Risk of Cardiovascular Disease Events Models 内镜下套筒胃成形术降低动脉粥样硬化性心血管疾病风险:一项使用合并队列方程和预测心血管疾病事件模型的队列研究
IF 0.9 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 DOI: 10.1016/j.tige.2025.250942
Ali Lahooti , Chino Aneke-Nash , Kate E. Johnson , Anam Rizvi , Muhammad U. Baig , Alpana Shukla , Carolyn Newberry , Emily Smith , Jude M. Sharaiha , Mark Hanscom , Kartik Sampath , David L. Carr-Locke , SriHari Mahadev , Sonal Kumar , Robert Schwartz , Samuel M. Kim , Reem Z. Sharaiha

BACKGROUND AND AIMS

Endoscopic sleeve gastroplasty (ESG) is a minimally invasive procedure for obesity, a risk factor for atherosclerotic cardiovascular disease (ASCVD). However, its impact on cardiovascular risk remains underexplored. This study evaluates ESG’s effects on ASCVD risk and obesity-related comorbidities.

METHODS

In this cohort study, 168 adults with obesity (aged 30-79 years; body mass index, ≥30 kg/m2 or ≥27 kg/m2; with comorbidities) underwent ESG at a single tertiary care facility from 2013 to 2024. Patients were evaluated at baseline and 12 months after procedure using the Pooled Cohort Equations (PCEs) for patients aged 40-79 years and the Predicting Risk of Cardiovascular Disease Events (PREVENT) equations for those aged 30-79 years. Changes in body weight, glycemic control, blood pressure, lipid profile (total cholesterol, low- and high-density lipoprotein cholesterol, triglycerides), and liver enzymes (alanine aminotransferase) were also analyzed.

RESULTS

Of the 168 patients (median age, 48 years; 74% female; body mass index, 36.0 kg/m2), 129 and 159 met inclusion criteria for PCEs and PREVENT equations, respectively. At 12 months, median PCEs ASCVD risk score decreased from 3.3% to 3.0% (21% reduction, P < 0.001), while the PREVENT 10-year cardiovascular disease risk score declined from 3.1% to 2.4% (20% reduction; P < 0.001), with similar reductions in 30-year risk scores and greater improvements in high/intermediate-risk patients and those aged >50 years. Patients achieved a median total body weight loss of 13.5% (IQR, 8.1%-18.6%), with significant metabolic improvements, and >80% experienced diabetes resolution. There was 1 (0.6%) moderate adverse event.

CONCLUSION

Adults who underwent ESG showed significant improvements in ASCVD risk and obesity-related comorbidities at 12 months after procedure. These findings suggest that ESG may be an effective intervention for managing obesity and mitigating cardiovascular risk in patients with obesity. ClincialTrials.gov identifier: NCT04494048.
背景:aimsenscopic sleeve gastroplasty (ESG)是一种治疗肥胖的微创手术,肥胖是动脉粥样硬化性心血管疾病(ASCVD)的危险因素。然而,其对心血管风险的影响仍未得到充分探讨。本研究评估ESG对ASCVD风险和肥胖相关合并症的影响。方法在这项队列研究中,168名肥胖成人(年龄30-79岁,体重指数≥30 kg/m2或≥27 kg/m2,有合并症)于2013年至2024年在一家三级医疗机构接受了ESG检查。在基线和手术后12个月,对40-79岁的患者使用合并队列方程(pce),对30-79岁的患者使用心血管疾病事件预测风险方程(prevention)进行评估。还分析了体重、血糖控制、血压、血脂(总胆固醇、低脂蛋白和高密度脂蛋白胆固醇、甘油三酯)和肝酶(丙氨酸转氨酶)的变化。结果168例患者(中位年龄48岁,女性占74%,体重指数36.0 kg/m2),分别有129例和159例符合pce和PREVENT方程的纳入标准。在12个月时,PCEs ASCVD风险评分中位数从3.3%下降到3.0%(降低21%,P < 0.001),而prevention 10年心血管疾病风险评分从3.1%下降到2.4%(降低20%,P < 0.001), 30年风险评分也有类似的降低,高/中危患者和50岁患者的改善更大。患者的中位总体重减轻13.5% (IQR, 8.1%-18.6%),代谢显著改善,80%的患者糖尿病得到缓解。有1例(0.6%)中度不良事件。结论:接受ESG的成年人在手术后12个月ASCVD风险和肥胖相关合并症有显著改善。这些发现表明,ESG可能是控制肥胖和减轻肥胖患者心血管风险的有效干预措施。ClincialTrials.gov识别码:NCT04494048。
{"title":"Endoscopic Sleeve Gastroplasty Reduces Atherosclerotic Cardiovascular Disease Risk: A Cohort Study Using Pooled Cohort Equations and Predicting Risk of Cardiovascular Disease Events Models","authors":"Ali Lahooti ,&nbsp;Chino Aneke-Nash ,&nbsp;Kate E. Johnson ,&nbsp;Anam Rizvi ,&nbsp;Muhammad U. Baig ,&nbsp;Alpana Shukla ,&nbsp;Carolyn Newberry ,&nbsp;Emily Smith ,&nbsp;Jude M. Sharaiha ,&nbsp;Mark Hanscom ,&nbsp;Kartik Sampath ,&nbsp;David L. Carr-Locke ,&nbsp;SriHari Mahadev ,&nbsp;Sonal Kumar ,&nbsp;Robert Schwartz ,&nbsp;Samuel M. Kim ,&nbsp;Reem Z. Sharaiha","doi":"10.1016/j.tige.2025.250942","DOIUrl":"10.1016/j.tige.2025.250942","url":null,"abstract":"<div><h3>BACKGROUND AND AIMS</h3><div>Endoscopic sleeve gastroplasty (ESG) is a minimally invasive procedure for obesity, a risk factor for atherosclerotic cardiovascular disease (ASCVD). However, its impact on cardiovascular risk remains underexplored. This study evaluates ESG’s effects on ASCVD risk and obesity-related comorbidities.</div></div><div><h3>METHODS</h3><div>In this cohort study, 168 adults with obesity (aged 30-79 years; body mass index, ≥30 kg/m<sup>2</sup> or ≥27 kg/m<sup>2</sup>; with comorbidities) underwent ESG at a single tertiary care facility from 2013 to 2024. Patients were evaluated at baseline and 12 months after procedure using the Pooled Cohort Equations (PCEs) for patients aged 40-79 years and the Predicting Risk of Cardiovascular Disease Events (PREVENT) equations for those aged 30-79 years. Changes in body weight, glycemic control, blood pressure, lipid profile (total cholesterol, low- and high-density lipoprotein cholesterol, triglycerides), and liver enzymes (alanine aminotransferase) were also analyzed.</div></div><div><h3>RESULTS</h3><div>Of the 168 patients (median age, 48 years; 74% female; body mass index, 36.0 kg/m<sup>2</sup>), 129 and 159 met inclusion criteria for PCEs and PREVENT equations, respectively. At 12 months, median PCEs ASCVD risk score decreased from 3.3% to 3.0% (21% reduction, <em>P</em> &lt; 0.001), while the PREVENT 10-year cardiovascular disease risk score declined from 3.1% to 2.4% (20% reduction; <em>P</em> &lt; 0.001), with similar reductions in 30-year risk scores and greater improvements in high/intermediate-risk patients and those aged &gt;50 years. Patients achieved a median total body weight loss of 13.5% (IQR, 8.1%-18.6%), with significant metabolic improvements, and &gt;80% experienced diabetes resolution. There was 1 (0.6%) moderate adverse event.</div></div><div><h3>CONCLUSION</h3><div>Adults who underwent ESG showed significant improvements in ASCVD risk and obesity-related comorbidities at 12 months after procedure. These findings suggest that ESG may be an effective intervention for managing obesity and mitigating cardiovascular risk in patients with obesity. ClincialTrials.gov identifier: NCT04494048.</div></div>","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 4","pages":"Article 250942"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145018506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IF 0.9 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01
{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 1","pages":"Article 150898"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146520327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IF 0.9 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01
{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 4","pages":"Article 250931"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146728659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cover 封面
IF 1.2 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 DOI: 10.1016/S2590-0307(25)00032-7
{"title":"Cover","authors":"","doi":"10.1016/S2590-0307(25)00032-7","DOIUrl":"10.1016/S2590-0307(25)00032-7","url":null,"abstract":"","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 3","pages":"Article 250937"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144713651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IF 0.9 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01
{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 1","pages":"Article 250904"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146520324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IF 0.9 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01
{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 1","pages":"Article 150899"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146520329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reopenable Clip-Over-the-Line Method for Troubleshooting Iatrogenic Gastrointestinal Perforations 诊断医源性胃肠道穿孔的可重新打开夹过线方法
IF 1.2 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 DOI: 10.1016/j.tige.2024.250901
Takeshi Yasuda, Narutoshi Ando, Tamae Hashimoto, Yoshiaki Kanai, Yoichi Sakamoto, Yuki Endo, Tomohiro Soda, Takako Akazawa, Tsuguhiro Matsumoto, Norihito Yamauchi, Akira Muramatsu, Hiromu Kutsumi
{"title":"Reopenable Clip-Over-the-Line Method for Troubleshooting Iatrogenic Gastrointestinal Perforations","authors":"Takeshi Yasuda,&nbsp;Narutoshi Ando,&nbsp;Tamae Hashimoto,&nbsp;Yoshiaki Kanai,&nbsp;Yoichi Sakamoto,&nbsp;Yuki Endo,&nbsp;Tomohiro Soda,&nbsp;Takako Akazawa,&nbsp;Tsuguhiro Matsumoto,&nbsp;Norihito Yamauchi,&nbsp;Akira Muramatsu,&nbsp;Hiromu Kutsumi","doi":"10.1016/j.tige.2024.250901","DOIUrl":"10.1016/j.tige.2024.250901","url":null,"abstract":"","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 1","pages":"Article 250901"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143158116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Efficacy and Safety of Needle-Knife Fistulotomy vs Standard Cannulation: A Practical Randomized Controlled Trial 针刀造瘘与标准插管的疗效和安全性比较:一项实用的随机对照试验
IF 0.9 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 DOI: 10.1016/j.tige.2025.250941
Aleksey Novikov , Shuji Mitsuhashi , Muhammad Hassaan Bashir , Mena Bakhit , Ian Holmes , Alexander Schlachterman , Austin Chiang , David Loren , Thomas Kowalski

BACKGROUND AND AIMS

Current literature suggests that needle-knife fistulotomy (NKF) technique should be reserved for expert advanced endoscopists. The aim of this study was to evaluate the efficacy and safety of NKF compared with those of standard cannulation (SC) for primary biliary access performed by advanced endoscopists with a range of experience, including advanced endoscopy trainees.

METHODS

In total, 186 patients were randomly assigned to either NKF or SC as means of primary biliary access and 137 patients were included in the final analysis (clinicaltrials.gov; NCT06694038). The primary outcome was incidence of post–endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. Secondary outcomes were biliary access success, time to biliary access, incidence of bleeding, and incidence of perforation.

RESULTS

Of the 137 procedures included in the study, 99 (72.3%) were carried out by advanced endoscopy trainees under supervision, 26 (19.0%) by advanced endoscopists without significant previous NKF experience, and 12 (8.8%) by an experienced advanced endoscopist with expertise in NKF. In the group that was randomized to SC, 6 (8.22%) patients developed pancreatitis vs 5 (7.81%) patients randomized to NKF arm (P = 0.93). Average time to biliary access within 20 minutes was significantly shorter with SC at 268 seconds (95% CI, 198-338 seconds) vs 380 seconds (95% CI, 292-466 seconds; P < 0.05) in the NKF arm.

CONCLUSION

NKF is a safe and effective technique for primary biliary access during ERCP performed by advanced endoscopists with a wide range of experience, with post-ERCP pancreatitis equivalent to SC. NKF, in this study, took slightly longer than SC to achieve bile duct access. Use of either or both techniques resulted in a 100% successful bile duct cannulation in patients with favorable anatomy.
背景和目的目前的文献表明针刀造瘘术(NKF)应该保留给高级内窥镜专家。本研究的目的是评估NKF与标准插管(SC)在初级胆道通路中的疗效和安全性,标准插管由具有丰富经验的高级内窥镜医师(包括高级内窥镜实习生)实施。方法共186例患者随机分配至NKF组或SC组作为初级胆道通路,137例患者被纳入最终分析(clinicaltrials.gov; NCT06694038)。主要结局是内镜后逆行胆管胰腺炎(ERCP)的发生率。次要结局是胆道通路的成功、到达胆道通路的时间、出血的发生率和穿孔的发生率。结果在纳入研究的137例手术中,99例(72.3%)由高级内窥镜培训生在监督下进行,26例(19.0%)由没有显著NKF经验的高级内窥镜医师进行,12例(8.8%)由具有NKF专业知识的经验丰富的高级内窥镜医师进行。在随机分配到SC组的患者中,6名(8.22%)患者发生胰腺炎,而随机分配到NKF组的患者中有5名(7.81%)患者发生胰腺炎(P = 0.93)。20分钟内到达胆道通路的平均时间显著缩短,SC组为268秒(95% CI, 198-338秒),而NKF组为380秒(95% CI, 292-466秒;P < 0.05)。结论在ERCP术后胰腺炎等同于SC的情况下,由经验丰富的高级内窥镜医师实施的NKF是一种安全有效的初级胆道通路技术。在本研究中,NKF比SC所需的时间稍长。在解剖结构良好的患者中,使用其中一种或两种技术均可100%成功地进行胆管插管。
{"title":"Comparative Efficacy and Safety of Needle-Knife Fistulotomy vs Standard Cannulation: A Practical Randomized Controlled Trial","authors":"Aleksey Novikov ,&nbsp;Shuji Mitsuhashi ,&nbsp;Muhammad Hassaan Bashir ,&nbsp;Mena Bakhit ,&nbsp;Ian Holmes ,&nbsp;Alexander Schlachterman ,&nbsp;Austin Chiang ,&nbsp;David Loren ,&nbsp;Thomas Kowalski","doi":"10.1016/j.tige.2025.250941","DOIUrl":"10.1016/j.tige.2025.250941","url":null,"abstract":"<div><h3>BACKGROUND AND AIMS</h3><div>Current literature suggests that needle-knife fistulotomy (NKF) technique should be reserved for expert advanced endoscopists. The aim of this study was to evaluate the efficacy and safety of NKF compared with those of standard cannulation (SC) for primary biliary access performed by advanced endoscopists with a range of experience, including advanced endoscopy trainees.</div></div><div><h3>METHODS</h3><div>In total, 186 patients were randomly assigned to either NKF or SC as means of primary biliary access and 137 patients were included in the final analysis (clinicaltrials.gov; NCT06694038). The primary outcome was incidence of post–endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. Secondary outcomes were biliary access success, time to biliary access, incidence of bleeding, and incidence of perforation.</div></div><div><h3>RESULTS</h3><div>Of the 137 procedures included in the study, 99 (72.3%) were carried out by advanced endoscopy trainees under supervision, 26 (19.0%) by advanced endoscopists without significant previous NKF experience, and 12 (8.8%) by an experienced advanced endoscopist with expertise in NKF. In the group that was randomized to SC, 6 (8.22%) patients developed pancreatitis vs 5 (7.81%) patients randomized to NKF arm (<em>P</em> = 0.93). Average time to biliary access within 20 minutes was significantly shorter with SC at 268 seconds (95% CI, 198-338 seconds) vs 380 seconds (95% CI, 292-466 seconds; <em>P</em> &lt; 0.05) in the NKF arm.</div></div><div><h3>CONCLUSION</h3><div>NKF is a safe and effective technique for primary biliary access during ERCP performed by advanced endoscopists with a wide range of experience, with post-ERCP pancreatitis equivalent to SC. NKF, in this study, took slightly longer than SC to achieve bile duct access. Use of either or both techniques resulted in a 100% successful bile duct cannulation in patients with favorable anatomy.</div></div>","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 4","pages":"Article 250941"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144865231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IF 0.9 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01
{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 3","pages":"Article 250924"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146242821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Techniques and Innovations in Gastrointestinal Endoscopy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1